Article info
Clinical and epidemiological research
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial
- Correspondence toPascal Hendrik Pieter de Jong, Department of Rheumatology, University Medical Center, ErasmusMC, Room Ee963a, Postbus 2040, 3000CA Rotterdam, Netherlands; p.h.p.dejong{at}erasmusmc.nl
Citation
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial
Publication history
- Accepted March 25, 2012
- First published June 7, 2012.
Online issue publication
December 12, 2012
Article Versions
- Previous version (7 June 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions